
DaShenLin Pharmaceutical Group Co., Ltd.
SSE:603233.SS
16.27 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 6,216.776 | 4,416.348 | 4,493.052 | 2,792.361 | 3,750.372 | 1,716.089 | 1,329.008 | 1,081.501 | 668.448 | 526.686 | 603.332 | 275.753 | 190.073 |
Short Term Investments
| 15.506 | 41.986 | 91.987 | 109.37 | 689.978 | -458.83 | -443.325 | -350.497 | -257.218 | -190.796 | 0 | 43.196 | 37.97 |
Cash and Short Term Investments
| 6,232.283 | 4,458.334 | 4,585.039 | 2,901.731 | 4,440.35 | 1,716.089 | 1,329.008 | 1,081.501 | 668.448 | 526.686 | 603.332 | 275.753 | 190.073 |
Net Receivables
| 1,703.317 | 1,670.528 | 1,021.81 | 743.824 | 432.322 | 355.693 | 480.415 | 246.564 | 206.813 | 110.912 | 0 | 80.919 | 58.238 |
Inventory
| 4,128.001 | 4,181.248 | 3,872.461 | 3,630.146 | 2,682.529 | 2,055.062 | 1,886.012 | 1,716.587 | 1,304.759 | 1,010.04 | 755.85 | 718.988 | 477.01 |
Other Current Assets
| 522.616 | 488.182 | 240.405 | 592.166 | 742.11 | 1,138.805 | 329.722 | 330.229 | 202.325 | 143.638 | 329.218 | 116.454 | 44.168 |
Total Current Assets
| 12,586.217 | 10,798.293 | 10,669.631 | 7,867.867 | 8,297.31 | 5,468.043 | 4,025.157 | 4,054.881 | 2,404.365 | 1,815.704 | 1,688.4 | 1,192.113 | 808.278 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 7,305.21 | 7,342.945 | 6,094.975 | 5,653.707 | 1,287.16 | 1,119.13 | 983.183 | 801.557 | 625.156 | 551.583 | 441.669 | 355.143 | 70.56 |
Goodwill
| 3,521.512 | 3,023.615 | 2,363.756 | 2,059.828 | 1,333.774 | 983.729 | 534.048 | 161.799 | 125.799 | 14.16 | 14.16 | 11.576 | 11.576 |
Intangible Assets
| 1,991.285 | 1,880.031 | 700.554 | 676.41 | 538.529 | 384.828 | 287.628 | 114.121 | 67.102 | 63.852 | 49.991 | 41.076 | 34.929 |
Goodwill and Intangible Assets
| 5,512.798 | 4,903.646 | 3,064.31 | 2,736.238 | 1,872.303 | 1,368.557 | 821.676 | 275.92 | 192.902 | 78.012 | 64.152 | 52.652 | 46.505 |
Long Term Investments
| 140.081 | 155.587 | 40.172 | 40.799 | -539.677 | 575.781 | 587.213 | 444.808 | 315.615 | 198.323 | 147.594 | 69.658 | 64.964 |
Tax Assets
| 231.611 | 214.483 | 186.306 | 157.57 | 41.529 | 38.377 | 23.001 | 16.611 | 2.432 | 1.383 | 1.258 | 1.122 | 0.994 |
Other Non-Current Assets
| 663.894 | 708.347 | 785.849 | 879.501 | 1,373.301 | 102.038 | 96.793 | 228.987 | 39.658 | 13.41 | 22.108 | 10.159 | 5.205 |
Total Non-Current Assets
| 13,853.593 | 13,325.008 | 10,171.612 | 9,467.815 | 4,034.616 | 3,203.884 | 2,511.866 | 1,767.883 | 1,175.763 | 842.711 | 676.781 | 488.733 | 188.227 |
Total Assets
| 26,439.81 | 24,123.301 | 20,841.243 | 17,335.682 | 12,331.926 | 8,671.928 | 6,537.023 | 5,822.764 | 3,580.129 | 2,658.415 | 2,365.181 | 1,680.847 | 996.506 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 8,433.011 | 6,870.514 | 6,127.385 | 4,737.831 | 4,214.827 | 3,199.62 | 2,549.583 | 2,116.925 | 1,499.572 | 1,156.581 | 1,064.928 | 639.173 | 354.326 |
Short Term Debt
| 1,778.217 | 759.733 | 697.309 | 165.438 | 190.859 | 68.84 | 331.381 | 486.379 | 351.577 | 179.697 | 215.65 | 280 | 126.195 |
Tax Payables
| 260.461 | 176.206 | 244.172 | 166.565 | 193.065 | 125.986 | 121.544 | 90.273 | 86.831 | 62.401 | 60.926 | 55.73 | 61.239 |
Deferred Revenue
| 0 | 0 | 435.726 | 1,348.149 | 1,055.988 | 689.474 | 121.544 | 354.832 | 307.709 | 202.028 | 198.353 | 159.518 | 133.462 |
Other Current Liabilities
| 3,235.156 | 3,647.106 | 2,203.011 | 757.623 | 1,550.999 | 608.395 | 290.062 | -51.075 | 255.914 | -59.472 | -59.227 | 105.666 | 73.281 |
Total Current Liabilities
| 13,706.845 | 11,453.56 | 9,707.603 | 7,175.606 | 5,468.47 | 4,002.841 | 3,414.114 | 2,997.334 | 2,193.894 | 1,541.235 | 1,678.984 | 1,080.569 | 615.041 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 4,542.435 | 4,707.689 | 4,251.518 | 4,204.077 | 3,779.822 | 260.446 | 21.446 | 0 | 28.8 | 80.64 | 96 | 10 | 0 |
Deferred Revenue Non-Current
| 17.416 | 0 | 17.642 | 20.122 | 83.273 | 76.937 | 14.759 | 22.759 | 15.35 | 15.35 | 15.35 | 0.35 | 0.35 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 1,252.149 | -0 | -260.446 | -21.446 | 0 | -28.8 | -80.64 | -96 | -10 | 0 |
Other Non-Current Liabilities
| 34.843 | 28.967 | 0.328 | 20.122 | 0 | 76.937 | 14.759 | 0 | 15.35 | 15.35 | 0 | 0.35 | 0 |
Total Non-Current Liabilities
| 4,594.695 | 4,736.656 | 4,269.488 | 4,224.199 | 1,290.556 | 337.384 | 36.205 | 22.759 | 44.15 | 95.99 | 111.35 | 10.35 | 0.35 |
Total Liabilities
| 18,301.54 | 16,190.216 | 13,977.091 | 11,399.804 | 6,759.026 | 4,340.225 | 3,450.32 | 3,020.093 | 2,238.044 | 1,637.225 | 1,790.334 | 1,090.919 | 615.391 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1,138.848 | 1,138.902 | 949.118 | 790.935 | 658.621 | 539.542 | 400.01 | 400.01 | 360 | 360 | 200 | 200 | 164.9 |
Retained Earnings
| 3,835.989 | 3,683.784 | 3,180.117 | 2,600.671 | 2,627.356 | 1,968.453 | 1,549.186 | 1,302.293 | 839.481 | 581.086 | 194.479 | 250.131 | 135.127 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 707.403 | 565.411 | 392.41 | 258.004 | 159.272 | 104.84 | 117.914 | 80.105 | -0 | -0 | 0 |
Other Total Stockholders Equity
| 1,922.408 | 2,001.167 | 2,082.647 | 2,086.972 | 2,098.828 | 1,473.905 | 1,088.916 | 1,050.472 | 117.914 | 80.105 | 105.666 | 71.293 | 28.234 |
Total Shareholders Equity
| 6,897.245 | 6,823.853 | 6,211.882 | 5,478.577 | 5,384.806 | 4,239.904 | 3,038.112 | 2,752.775 | 1,317.395 | 1,021.19 | 500.145 | 525.643 | 328.261 |
Total Equity
| 8,138.27 | 7,933.085 | 6,864.152 | 5,935.877 | 5,572.9 | 4,331.703 | 3,086.703 | 2,802.671 | 1,342.085 | 1,021.19 | 574.847 | 589.927 | 381.115 |
Total Liabilities & Shareholders Equity
| 26,439.81 | 24,123.301 | 20,841.243 | 17,335.682 | 12,331.926 | 8,671.928 | 6,537.023 | 5,822.764 | 3,580.129 | 2,658.415 | 2,365.181 | 1,680.847 | 996.506 |